Source:http://linkedlifedata.com/resource/pubmed/id/11846943
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2002-2-15
|
pubmed:abstractText |
We previously demonstrated that administration of 7.5% hypertonic saline (HS) significantly improved spinal cord blood flow and neurological outcomes after spinal cord injury. The aim of this study was to determine whether hypertonicity would enhance the effects of methylprednisolone (MP), further improving neurological function.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0148-396X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1427-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11846943-Animals,
pubmed-meshheading:11846943-Drug Therapy, Combination,
pubmed-meshheading:11846943-Female,
pubmed-meshheading:11846943-Injections, Intravenous,
pubmed-meshheading:11846943-Locomotion,
pubmed-meshheading:11846943-Methylprednisolone,
pubmed-meshheading:11846943-Rats,
pubmed-meshheading:11846943-Rats, Sprague-Dawley,
pubmed-meshheading:11846943-Saline Solution, Hypertonic,
pubmed-meshheading:11846943-Spinal Cord Injuries
|
pubmed:year |
2001
|
pubmed:articleTitle |
Coadministration of methylprednisolone with hypertonic saline solution improves overall neurological function and survival rates in a chronic model of spinal cord injury.
|
pubmed:affiliation |
Department of Physiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|